News

Wugen Raises $172 Million to Advance Clinical Stage Memory NK Cell Platform, Progress Best-In-Class AML Program, and Initiate Multiple Solid Tumor Trials

Wugen Raises $172 Million to Advance Clinical Stage Memory NK Cell Platform, Progress Best-In-Class AML Program, and Initiate Multiple Solid Tumor Trials

July 15, 2021 Press Releases

Proceeds to advance clinical development of WU-NK-101 for relapsed/refractory AML, and initiate studies in solid

Read More
ST. LOUIS

4340 Duncan Ave
Suite 302
St. Louis, MO 63110

SAN DIEGO

9880 Campus Point Dr
Suite 420
San Diego, CA 92121

SOCIAL
Copyright © 2021 Wugen. All Rights Reserved.

a COGNEO design